title: Functional selectivity and dualsteric/bitopic GPCR targeting.
abstract: Functional selectivity provides a new avenue to selectively engage particular pathways of the pleiotropic signaling repertoire of a G protein-coupled receptor. First examples for signaling biased compounds at the angiotensin II receptor and the μ opioid receptor have progressed to clinical trials and are promising in regard to selective activation of signaling pathways that can be linked to beneficial clinical outcomes. Dualsteric/bitopic hybrid compounds which consist of at least two pharmacophores combined in one single ligand are more recent examples for functionally selective ligands. Their binding topography makes them ideally suited to disrupt receptor flexibility and rationally induce signaling bias. Therefore, the dualsteric/bitopic design principle is most promising to facilitate generation of structurally diverse biased agonists at G protein-coupled receptors.
authors.affiliation: Pharmacology and Toxicology Section, Institute of Pharmacy, University of Bonn, Gerhard-Domagk-Straße 3, 53121 Bonn, Germany. Electronic address: rschrage@uni-bonn.de.
authors.forename: Ramona
authors.initials: R
authors.lastname: Schrage
authors.affiliation: Molecular-, Cellular-, and Pharmacobiology Section, Institute of Pharmaceutical Biology, University of Bonn, Nussallee 6, 53115 Bonn, Germany. Electronic address: kostenis@uni-bonn.de.
authors.forename: Evi
authors.initials: E
authors.lastname: Kostenis
mesh_terms: D000818:Animals; D015195:Drug Design; D006801:Humans; D008024:Ligands; D058990:Molecular Targeted Therapy; D011485:Protein Binding; D011945:Receptors, Angiotensin / Q000819:agonists / Q000378:metabolism; D043562:Receptors, G-Protein-Coupled / Q000819:agonists* / Q000378:metabolism; D017450:Receptors, Opioid, mu / Q000819:agonists / Q000378:metabolism; D015398:Signal Transduction / Q000187:drug effects*
chemical_list: D008024:Ligands; D011945:Receptors, Angiotensin; D043562:Receptors, G-Protein-Coupled; D017450:Receptors, Opioid, mu